One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
Zimmer Biomet warns on some StageOne bone spacer molds
Zimmer Biomet (NYSE:ZBH) issued an urgent field safety notice in Europe to warn on certain StageOne and StageOne Select bone cement spacer molds due to potentially insufficient cleaning and monitoring. According to the notice, certain devices may have undergone an insufficient cleaning process or were subject to potentially inadequate process monitoring for cleaning parameters. More than […]
Medical device company stocks aren’t immune from coronavirus
Major U.S. medical device company stocks have generally performed as poorly as others over the past two weeks as the global coronavirus outbreak drive markets down. Among 20 of the largest U.S. companies on Medical Design & Outsourcing and MassDevice‘s annual Big 100 list, both the average and median decline in price was roughly 17% […]
Zimmer Biomet stock up more than 5% on Street-beating results
Zimmer Biomet (NYSE:ZBH) reported fourth-quarter results today that beat the consensus forecast on Wall Street, announcing a number of new restructuring initiatives. The Warsaw, Ind.–based orthopedic device giant reported profits of $321.4 million, or $1.54 per share, off sales of $2.13 billion for the three months ended Dec. 31, 2019, versus a loss of –$902.5 million, […]
These medical device companies provide the most research payments
The worlds largest medical device companies are spending tens of millions of dollars a year on research payments to doctors and teaching hospitals — but the payments only make up a tiny fraction of their budgets. That was a big takeaway from an analysis of Medical Design & Outsourcing‘s annual Big 100 and the most […]
Zimmer Biomet appoints new SVP of investor relations and chief communications officer
Zimmer Biomet (NYSE:ZBH) today said it appointed Keri Mattox as the new senior VP of investor relations and chief communications officer. She will be responsible for strategically integrating, aligning and driving investor relations, communications and philanthropy functions and activities within Zimmer Biomet. Mattox has more than two decades of investor relations and communications experiences within the […]
Report: Appeals court revives hip implant lawsuit against Zimmer-Biomet
A federal appeals court has reinstated a personal-injury lawsuit against Zimmer Biomet (NYSE:ZBH) over a metal-on-metal hip prosthesis implanted in 2011. The Third Circuit Court of Appeals revived the lawsuit that a Pennsylvania U.S. District Court judge dismissed in August 2018 because it missed the statute of limitations, according to an article by Law 360. […]
These medical device companies pay doctors the most money
The top medical device companies in the world made more than $542.6 million in general payments to physicians and hospitals in 2018, according to an analysis of Medical Design & Outsourcing‘s Big 100 and CMS Open Payments data. Zimmer Biomet topped the list with $109.4 million in general payments* to physicians and teaching hospitals in […]
FDA puts Class I label on Zimmer Biomet’s Rosa Brain robot software recall
The FDA has given a recall on the Zimmer Biomet (NYSE:ZBH) Rosa Brain 3.0 devices for robot-assisted neurosurgery procedures a Class I designation, the most serious type of recall. Zimmer Biomet warned in September of the problem, in which a sequence workflow can trigger “a discrepancy between initial skin marking on the skull and instrument trajectory,” […]
Ex-Biomet worker in Brazilian bribery case loses appeal in defamation suit
A former Zimmer Biomet (NYSE:ZBH) employee can’t pursue defamation charges against the company related to his alleged involvement in a Brazilian bribery case, a federal appeals court ruled yesterday. In 2008 Biomet discovered that a distributor in Brazil, Sergio Galindo, had bribed healthcare providers to use its products. The company severed its relationship with Galindo and […]
Supremes deny Zimmer Biomet in $250m loss to Stryker
The U.S. Supreme Court today declined to take up the Zimmer Biomet (NYSE:ZBH) appeal of a $248 million loss to Stryker (NYSE:SYK) in a patent infringement case. The case dates back to December 2010, when Stryker sued orthopedics rival Zimmer, alleging infringement of 3 patents covering wound debridement technology by Zimmer’s Pulsavac Plus device. Last December the U.S. Court […]
- 1
- 2
- 3
- …
- 38
- Next Page »
